São Paulo, São Paulo, Brazil
Professional with robust expertise in Medical Affairs, 23 years working in huge pharmaceutical companies (medical manager, MSL, medical information and clinical trials). Robust experience in multiple therapeutic areas, with in-depth knowledge of the oncology and hematology market. Participation in international medical congress (Oncolology and Hematology) • American Society Clinical Oncology - ASCO – (Chicago/USA: 2017, 2018, 2019, 2020, 2021) • Annual Meeting of the American Society of Hematology – ASH - (2016, 2017, 2018, 2019, 2020, 2023, 2024) • Fórum Latino Americano e Fórum Brasileiro de Biossimilares - FLAB (2016, 2017, 2018, 2019) • European Society for Medical Oncology – ESMO (Munique/Alemanha 2018) • San Antonio Breast Cancer Symposium – SABCS ( San Antonio/Texas: 2018, 2019) • The European Hematology Association – EHA – (2019, 2020, 2023, 2024)
Advocacy development regarding some onco-hematological product with KOL´s in Brazil; Build strong networks to help opinion leaders and decision makers with scientific information and support; Provide and discuss update scientific information with health professionals; Provide scientific support and training to company employees (eg representation of sales, clinical research assistants); Identify business opportunities; National and international medical congresses participation; Planning and execution of medical classes and mentoring/ training of junior MSLs.
Advocacy development regarding antimicrobial products with KOL´s in Brazil; Build strong networks to help opinion leaders and decision makers with scientific information and support; Provide and discuss update scientific information with health professionals; Provide scientific support and training to company employees (eg representation of sales, clinical research assistants); Identify business opportunities.
*Advocacy development regarding some biosimilar products (monoclonal antibodies) among key opinion leaders (KOLs) in Brazil. *Identification of potential third party studies (investigator initiative trial) that are strategic to the product’s current marketing plan. *Assistance in protocol writing, regulatory submission and also general scientific support for the investigator, his team and the company’s Medical Affairs team. *Develop and identify clinical researchers to conduct clinical trials and develop new clinical trial sites in Brazil. *Develop professional relationships, build strong networks to help opinion leaders and decision makers with scientific information and support. *Provide and discuss update scientific information with health professionals, ensuring quality and accuracy of medical and scientific information. *Provide scientific support and training (eg health and products) to company employees (eg representation of sales, clinical research assistants, etc.). *Identify business opportunities.
*Advocacy development regarding some biosimilar products (monoclonal antibodies) among key opinion leaders (KOLs) in Brazil. *Identification of potential third party studies (investigator initiative trial) that are strategic to the product’s current marketing plan. *Assistance in protocol writing, regulatory submission and also general scientific support for the investigator, his team and the company’s Medical Affairs team. *Develop and identify clinical researchers to conduct clinical trials and develop new clinical trial sites in Brazil. *Develop professional relationships, build strong networks to help opinion leaders and decision makers with scientific information and support. *Provide and discuss update scientific information with health professionals, ensuring quality and accuracy of medical and scientific information. *Provide scientific support and training (eg health and products) to company employees (eg representation of sales, clinical research assistants, etc.).
Coordinating a temporary project, that includes scientific classification (taxonomy) of more than 3000 scientific papers, published by researchers from Butantan Institute and USP in a new data base.